Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer

被引:91
|
作者
Jeong, Hasong [1 ]
Hwang, Ilseon [1 ]
Kang, Sun Hee [2 ]
Shin, Hyeong Chan [3 ]
Kwon, Sun Young [1 ]
机构
[1] Keimyung Univ, Sch Med, Dept Pathol, 56 Dalsung Ro, Daegu 41931, South Korea
[2] Keimyung Univ, Dept Gen Surg, Sch Med, Daegu, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea
关键词
Breast neoplasms; CD11c antigen; CD163; antigen; CD68; Macrophages; CLINICAL ONCOLOGY/COLLEGE; ALTERNATIVE ACTIVATION; AMERICAN SOCIETY; EXPRESSION; RECOMMENDATIONS; RECEPTORS; MARKERS;
D O I
10.4048/jbc.2019.22.e5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely, M2 shows immunosuppressive action and promotes tumor growth. There are various markers of TAMs. CD11c is considered as a specific marker of M1. CD163 is an optimal marker for M2. CD68 is known as a panmacrophage marker. We evaluated the relationship between the clinicopathological parameters and immunohistochemical expressions of CD11c, CD163, and CD68 in invasive breast cancer (IBC), and the prognostic value of macrophage localization within the tumor stroma (TS) and tumor nest (TN). Methods: Immunohistochemistry of CD68, CD11c, and CD163 was analyzed on tissue microarrays of 367 IBCs. The number of CD68+, CD11c+, or CD163+ macrophages in TN vs. TS was counted by 2 pathologists. The correlations between the degree of macrophage (CD68+, CD11c+, or CD163+) infiltration and the clinicopathological parameters were analyzed. We also assessed the impact of macrophages (CD68+, CD11c+, or CD163+) on disease free survival (DFS) and overall survival (OS). Results: High numbers of macrophages (CD68+, CD11c+, or CD163+) were associated with higher histologic grade, higher Ki-67 proliferating index, estrogen receptor negativity, and progesterone receptor negativity. High numbers of macrophages (CD11c+ or CD163+) in TS were associated with a larger tumor size. Furthermore, CD163+ macrophages in TN were an independent prognostic marker of reduced OS and DFS. Conversely, CD11c+ macrophages in TS were an independent prognostic marker for higher OS and DFS. Conclusion: TAMs, including M2 type, are associated with tumor progression in IBC. They can also act as a significant unfavorable or favorable prognostic factor. In addition to simply analyzing the degree of TAM infiltration, it is also important to analyze the location of TAMs.
引用
收藏
页码:38 / 51
页数:14
相关论文
共 50 条
  • [31] Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma
    Shorouk E. Mwafy
    Dina M. El-Guindy
    [J]. Journal of the Egyptian National Cancer Institute, 32
  • [32] Tumour-associated macrophages in tumour stroma as potential diagnostic and prognostic biomarkers in breast cancer
    Wang, W.
    Xu, Z. L.
    Guo, Y. C.
    Wang, K. R.
    Xing, H.
    Song, C. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S199 - S199
  • [33] Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer
    Gwak, Jae Moon
    Jang, Min Hye
    Kim, Dong Il
    Seo, An Na
    Park, So Yeon
    [J]. PLOS ONE, 2015, 10 (04):
  • [34] Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
    Feng, Qingyang
    Chang, Wenju
    Mao, Yihao
    He, Guodong
    Zheng, Peng
    Tang, Wentao
    Wei, Ye
    Ren, Li
    Zhu, Dexiang
    Ji, Meiling
    Tu, Yongjiu
    Qin, Xinyu
    Xu, Jianmin
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3896 - 3907
  • [35] Targeting Tumor-Associated Macrophages in Cancer
    Pathria, Paulina
    Louis, Tiani L.
    Varner, Judith A.
    [J]. TRENDS IN IMMUNOLOGY, 2019, 40 (04) : 310 - 327
  • [36] Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
    Qiu, Si-Qi
    Waaijer, Stijn J. H.
    Zwager, Mieke C.
    de Vries, Elisabeth G. E.
    van der Vegt, Bert
    Schroeder, Carolien P.
    [J]. CANCER TREATMENT REVIEWS, 2018, 70 : 178 - 189
  • [37] Tumor-associated macrophages heterogeneity is driven by distinct niches in breast cancer
    Laviron, Marie
    Petit, Maxime
    Delacroix, Eleonore Weber
    Combes, Alexis J.
    Rao, Arjun Arkal
    Barthelemy, Sandrine
    Courau, Tristan
    Hume, David A.
    Combadiere, Christophe
    Krummel, Matthew F.
    Boissonnas, Alexandre
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 74 - 74
  • [38] Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
    Laoui, Damya
    Movahedi, Kiavash
    Van Overmeire, Eva
    Van den Bossche, Jan
    Schouppe, Elio
    Mommer, Camille
    Nikolaou, Alexandros
    Morias, Yannick
    De Baetselier, Patrick
    Van Ginderachter, Jo A.
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2011, 55 (7-9): : 861 - 867
  • [39] Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression
    Li, Yan
    Ganesan, Kumar
    Chen, Jianping
    [J]. CURRENT MEDICINAL CHEMISTRY, 2022, 29 (33) : 5420 - 5440
  • [40] Targeting tumor-associated macrophages as a novel strategy against breast cancer
    Luo, Yunping
    Zhou, He
    Krueger, Joerg
    Kaplan, Charles
    Lee, Sung-Hyung
    Dolman, Carrie
    Markowitz, Dorothy
    Wu, Wenyuan
    Liu, Cheng
    Reisfeld, Ralph A.
    Xiang, Rong
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08): : 2132 - 2141